This inventor holds 10 USPTO granted patents and 6 published patent applications and 3 EPO patents. Top assignee: Vanderbilt University. Active years: 2018-2025.
Location History:
- Mufreesboro, TN (US) (2018)
- Murfeesboro, TN (US) (2019)
- Murfreesboro, TN (US) (2019 - 2022)
Company Filing History:
Years Active: 2018-2025
Title: The Innovations of Sean R Bollinger
Introduction
Sean R Bollinger is a prominent inventor based in Murfreesboro, TN (US). He has made significant contributions to the field of neuroscience through his innovative work. With a total of 10 patents to his name, Bollinger is recognized for his advancements in the treatment of neurological dysfunction.
Latest Patents
Bollinger's latest patents include the development of indazole compounds as mGluR4 allosteric potentiators. These compounds serve as positive allosteric modulators of the metabotropic glutamate receptor subtype 4 (mGluR4). His patents detail synthetic methods for creating these compounds, as well as pharmaceutical compositions that incorporate them. The methods outlined in his patents aim to treat neurological and psychiatric disorders, particularly those associated with glutamate dysfunction.
Career Highlights
Bollinger is affiliated with Vanderbilt University, where he continues to push the boundaries of research in his field. His work has garnered attention for its potential impact on treating various neurological conditions.
Collaborations
Some of Bollinger's notable coworkers include P Jeffrey Conn and Craig William Lindsley. Their collaborative efforts contribute to the advancement of research in neuroscience and pharmacology.
Conclusion
Sean R Bollinger's innovative work in developing compounds for treating neurological dysfunction showcases his dedication to improving health outcomes. His contributions to the field are significant and continue to influence research and treatment methodologies.